ATINYSE: ATI

Robert S. Wetherbee becomes Executive Chairman DALLAS , July 1, 2024 /PRNewswire/ -- Kimberly A. Fields today became President and CEO of ATI Inc. [NYSE: ATI].

Here is how Allegheny Technologies (ATI) and Kronos Worldwide (KRO) have performed compared to their sector so far this year.

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND submission to the FDA Engaging regulatory authorities to align on ATI-1801 development plans  HALIFAX, Nova Scotia, June 25, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the fiscal year ended March 31, 2024 (“FYE 2024”), and provided an update on the Company's strategy for fiscal 2025. All figures are stated in Canadian dollars unless otherwise stated.

Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ResearchAndMarkets.com's offering. The 7 major rheumatoid arthritis markets reached a value of US$ 27.5 billion in 2023. Looking forward, the 7MM are projected to reach US$ 33.8 billion by 2034, exhibiting a growth rate (CAGR) of 2.32% during 2023-2034.

The AA&S segment remains weak but showing improvement, and the HPMC segment continues to show strength. Strong demand primarily in the A&D end market should continue to drive growth in the quarters ahead. Expected revenue growth, strong pricing and operational improvement should benefit margin.

Commercial aerospace has seen more than its share of bad press, with the latest being a report of faulty titanium components making it into Airbus and Boeing planes. Given how ATI sources its titanium, I see little direct risk to the company, but can't rule out that this leads to further interruptions in 2024 production schedules. Despite ongoing production challenges in the aerospace sector, ATI has a long runway ahead for revenue growth and margin improvement as widebody production accelerates in 2025 and 2026.

ATI shares have enjoyed a strong surge in 2024 on the strength of two good earnings reports. One Wall Street analyst is moving the company to neutral from a buy after the run.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

DALLAS , June 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) Chief Financial Officer Don Newman will speak at the 2024 Wells Fargo Industrials Conference in Chicago, IL, on June 11, 2024, at 12:45 p.m. CT.  The link to the fireside chat is available at the News & Events section of www.ATImaterials.com/investors.